Biomarkers

Coming soon: a Breathalyzer for diabetes?

University of Pittsburgh researchers are developing a Breathalyzer than can detect and possibly monitor diabetes.

Biomarkers not the endpoint

By

The Food and Drug Administration issued guidance in February for clinical trials for early-stage Alzheimer's medications.

FDA draft guidelines suggest route to approval for early-stage Alzheimer's drugs

FDA draft guidelines suggest route to approval for early-stage Alzheimer's drugs

By

The Food and Drug Administration issued draft guidance Thursday on clinical trials for early-stage Alzheimer's drugs.

Scientists developing blood test for Alzheimer's

Scientists have developed an antibody-screening blood test that may one day be used to detect diseases such as Alzheimer's.

International experts propose new criteria for diagnosing Alzheimer's

An international group of dementia experts is proposing a change in the definition of Alzheimer's disease. They want to be able to diagnose the condition earlier and provide interventional treatments, according to recent reports.